Chloramphenicol
- CAS No.
- 56-75-7
- Chemical Name:
- Chloramphenicol
- Synonyms
- CAF;Levomycetin;CHLORAMPHENICOL LEVO;D-2-DICHLOROACETAMIDO-1-P-NITRO-PHENYL-1,3-PROPANEDIOL;CHLORAMPHENICAL;Chloroamphenicol;Chloroptic;econochlor;Ophthochlor;CHLOROMYCETIN
- CBNumber:
- CB3364529
- Molecular Formula:
- C11H12Cl2N2O5
- Molecular Weight:
- 323.13
- MOL File:
- 56-75-7.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/7/11 8:43:34
| Melting point | 148-150 °C(lit.) |
|---|---|
| Boiling point | 644.9±55.0 °C(Predicted) |
| alpha | 19.5 º (c=6, EtOH) |
| Density | 1.6682 (rough estimate) |
| refractive index | 20 ° (C=5, EtOH) |
| Flash point | 14 °C |
| storage temp. | Keep in dark place,Inert atmosphere,2-8°C |
| solubility | absolute ethanol: soluble5-20mg/mL (as a stock solution) |
| pka | 11.03±0.46(Predicted) |
| form | powder |
| color | white |
| Water Solubility | 2.5 g/L (25 º C) |
| Merck | 14,2077 |
| BRN | 2225532 |
| BCS Class | 3 |
| InChIKey | WIIZWVCIJKGZOK-RKDXNWHRSA-N |
| LogP | 1.140 |
| CAS DataBase Reference | 56-75-7(CAS DataBase Reference) |
| IARC | 2A (Vol. Sup 7, 50) 1990 |
| NIST Chemistry Reference | Chloramphenicol(56-75-7) |
| EPA Substance Registry System | Chloramphenicol (56-75-7) |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS05,GHS08 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H318-H351-H361fd | |||||||||
| Precautionary statements | P202-P280-P305+P351+P338-P308+P313-P405-P501 | |||||||||
| Hazard Codes | T,F | |||||||||
| Risk Statements | 45-11-39/23/24/25-23/24/25 | |||||||||
| Safety Statements | 53-45-16-36/37 | |||||||||
| RIDADR | 2811 | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | AB6825000 | |||||||||
| F | 3-10 | |||||||||
| TSCA | Yes | |||||||||
| HazardClass | 3 | |||||||||
| HazardClass | IRRITANT | |||||||||
| HS Code | 29414000 | |||||||||
| Toxicity | LD50 oral in rat: 2500mg/kg | |||||||||
| NFPA 704 |
|
Chloramphenicol price More Price(32)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich(India) | SRP5116 | PCAF (431-end), GST tagged human recombinant, expressed in E. coli, ≥70% (SDS-PAGE), buffered aqueous glycerol solution | 2226026-74-8 | 50μG | ₹53033.4 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | R4408 | Chloramphenicol Ready Made Solution, 100?mg/mL in ethanol: isopropanol (95:5), ≥98% (HPLC) | 56-75-7 | 10ML | ₹7088.9 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | C1919 | Chloramphenicol BioReagent, suitable for plant cell culture | 56-75-7 | 5G | ₹5683.13 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | PHR1412 | Chloramphenicol Pharmaceutical Secondary Standard; Certified Reference Material | 56-75-7 | 1G | ₹8281.13 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | C7795 | Chloramphenicol γ-irradiated | 56-75-7 | 20MG | ₹1732 | 2022-06-14 | Buy |
Chloramphenicol Chemical Properties,Uses,Production
Description
Chloramphenicol was originally produced by fermentation of Streptomyces venezuelae, but its comparatively simple chemical structure soon resulted in several efficient total chemical syntheses. With two asymmetric centers, it is one of four diastereomers, only one of which (1R,2R) is significantly active. Because total synthesis produces a mixture of all four, the unwanted isomers must be removed before use. Chloramphenicol is a neutral substance that is only moderately soluble in water, because both nitrogen atoms are nonbasic under physiologic conditions (one is an amide and the other a nitro moiety). It was the first broad-spectrum oral antibiotic used in the United States and was once very popular. Severe potential blood dyscrasia has greatly decreased its use in North America. Although its cheapness and efficiency makes it still very popular in much of the rest of the world where it can often be purchased over-the-counter without a prescription
Chemical Properties
Chloramphenicol is a white to grayish-white or yellowish-white crystalline solid.
Uses
Chloramphenicol is unusual nitroaromatic metabolite produced by Streptomyces venezuelae, first published in 1947. Chloramphenicol is a broad spectrum antibiotic with good activity against Gram negative and anaerobic bacteria. Although restricted to ocular use, antibiotic resistance to other classes has refocused attention on this class. Chloramphenicol acts by binding to the 23S sub-unit of the 50S ribosome, inhibiting protein synthesis. Chloramphenicol has been extensively studied with over 35,000 literature citations.
Indications
Resistance to chloramphenicol is usually explained by the presence of a plasmid that
determines the production of chloramphenicol acetyltransferase. This enzyme acetylates
the drug, giving it unable to bind with 50 S subunits of bacterial ribosomes.
Chloramphenicol is a potentially toxic drug and has a few indications for use. It is the drug
of choice for treating typhoid fever, and it is used for treating brain abscesses. Until
recently, it was the drug of choice for therapy of bacterial meningitis in children (in combination with ampicillin). However, third-generation cephalosporins are currently preferred for such purposes. Chloramphenicol is an effective alternative for a number of
infections in situations, where drugs of choice cannot be used for one reason or another.
However, it should never be used for infections that can readily be treated with other
antimicrobial drugs. Synonyms of this drug are levomycetin, amindan, aquamycetin,
chloromycetin, ophthoclor, opulets, leukomycin, and many others.
Definition
ChEBI: Chloramphenicol is an organochlorine compound that is dichloro-substituted acetamide containing a nitrobenzene ring, an amide bond and two alcohol functions. It has a role as an antimicrobial agent, an antibacterial drug, a protein synthesis inhibitor, an Escherichia coli metabolite, a Mycoplasma genitalium metabolite and a geroprotector. It is an organochlorine compound, a diol, a C-nitro compound and a carboxamide.
World Health Organization (WHO)
Chloramphenicol, an antibiotic isolated from Streptomyces venezuelae in 1947, first became available for general clinical use in 1948. By 1950 it was evident that its use could cause serious, sometimes fatal, blood dyscrasias. However, it remains one of the most effective antibiotics for treating invasive typhoid fever and salmonellosis, some rickettsioses and serious infections caused by Haemophilus influenzae or anaerobic organisms. This is considered to justify its retention in the WHO Model List of Essential Drugs. (Reference: (WHTAC1) The Use of Essential Drugs, 2nd Report of the WHO Expert Committee, 722, , 1985)
General Description
Synthetic bacteriostatic antibiotic that inhibits the translation of RNA by blocking the peptidyltransferase reaction on ribosomes.
Hazard
Has deleterious and dangerous side effects. Must conform to FDA labeling requirements. Use is closely restricted. Probable carcinogen.
Contact allergens
This broad spectrum phenicol group antibiotic has been implicated in allergic contact dermatitis. Cross-sensitivity to thiamphenicol is possible, but not systematic.
Mechanism of action
Chloramphenicol is bacteriostatic by virtue of inhibition of protein biosynthesis in both bacterial and, to a
lesser extent, host ribosomes. Chloramphenicol binds to the 50S subparticle in a region near where the
macrolides and lincosamides bind.
Resistance is mediated by several R-factor enzymes that catalyze acetylation of the secondary and, to some
extent, the primary hydroxyl groups in the aliphatic side chain. These products no longer bind to the
ribosomes and so are inactivated. Escherichi a coli frequently is resistant because of chloramphenicol's lack
of intercellular accumulation.
Safety Profile
Confirmed human carcinogen producing leukemia, aplastic anemia, and other bone marrow changes. Experimental tumorigenic data. Poison by intravenous and subcutaneous routes. Moderately toxic by ingestion and intraperitoneal routes. Human systemic effects by an unknown route: changes in plasma or blood volume, unspecified liver effects, and hemorrhaging. Experimental teratogenic and reproductive effects. Human mutation data reported. An antibiotic. When heated to decomposition it emits very toxic fumes of NOx and Cl-. See also other chloramphenicol entries.
Potential Exposure
An antibiotic derived from streptomyces venezuelae. A potential danger to those involved in the manufacture, formulation, and application of this antibiotic and antifungal agent
Carcinogenicity
Chloramphenicol is reasonably anticipated to be a human carcinogen, based on limited evidence of carcinogenicity from studies in humans.
Environmental Fate
As an antibiotic, chloramphenicol enters the target cells by facilitated diffusion and binds reversibly to the 50S ribosomalsubunit. This prevents the interaction between peptidyl transferase and its amino acid substrate, which results in the inhibition of peptide bond formation. Indeed, it is an inhibitor of protein synthesis in the bacteria and to a lesser extent, in eukaryotic cells. Chloramphenicol can also inhibit mitochondrial protein synthesis in mammalian cells particularly erythropoietic cells, which are sensitive to the drug.
Metabolic pathway
Six metabolites of chloramphenicol are identified, among which the sulfate conjugate is characterized in goat urine.
Metabolism
When given orally, it is rapidly and completely absorbed but has a fairly short half-life. It is mainly excreted in the urine in the form of its metabolites, which are a C-3 glucuronide, and, to a lesser extent, its deamidation product and the product of dehalogenation and reduction. These metabolites are all inactive. The aromatic nitro group also is reduced metabolically, and this product can undergo amide hydrolysis. The reduction of the nitro group, however, does not take place efficiently in humans but, rather, primarily occurs in the gut by the action of the normal flora. Chloramphenicol potentiates the activity of some other drugs by inducing liver metabolism. Such agents include anticoagulant coumarins, sulfonamides, oral hypoglycemics, and phenytoin.
Shipping
UN3249 Medicine, solid, toxic, n.o.s., Hazard Class: 6.1; Labels: 6.1-Poisonous materials. UN2811 Toxic solids, organic, n.o.s., Hazard Class: 6.1; Labels: 6.1- Poisonous materials, Technical Name Required.
Purification Methods
Purify chloramphenicol by recrystallisation from H2O (solubility is 2.5mg/mL at 25o) or ethylene dichloride as needles or long plates, and by sublimation at high vacuum. It has A 1cm 298 at max 278nm, and it is slightly soluble in H2O (0.25%) and propylene glycol (1.50%) at 25o but is freely soluble in MeOH, EtOH, BuOH, EtOAc and Me2CO. [Relstock et al. J Am Chem Soc 71 2458 1949, Confroulis et al. J Am Chem Soc 71 2463 1949, Long & Troutman J Am Chem Soc 71 2469, 2473 1949, Ehrhart et al. Chem Ber 90 2088 1957, Beilstein 13 IV 2742.]
Incompatibilities
Compounds of the carboxyl group react with all bases, both inorganic and organic (i.e., amines), releasing substantial heat, water, and a salt that may be harmful. Incompatible with arsenic compounds (releases hydrogen cyanide gas), diazo compounds, dithiocarbamates, isocyanates, mercaptans, nitrides, sulfides (releasing heat, toxic, and possibly flammable gases), thiosulfates, and dithionites (releasing hydrogen sulfate and oxides of sulfur).
Waste Disposal
It is inappropriate and possibly dangerous to the environment to dispose of expired or waste pharmaceuticals by flushing them down the toilet or discarding them to the trash. Household quantities of expired or waste pharmaceuticals may be mixed with wet cat litter or coffee grounds, double-bagged in plastic, discard in trash. Larger quantities shall carefully take into consideration applicable DEA, EPA, and FDA regulations. If possible return the pharmaceutical to the manufacturer for proper disposal being careful to properly label and securely package the material. Alternatively, the waste pharmaceutical shall be labeled, securely packaged, and transported by a state licensed medical waste contractor to dispose by burial in a licensed hazardous or toxic waste landfill or incinerator.
Chloramphenicol Preparation Products And Raw materials
Raw materials
1of5
chevron_rightPreparation Products
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| Mehta Pharmaceutical Industries | +91-8390068777 +91-8390068777 | Mumbai, India | 30 | 58 | Inquiry |
| Anuh Pharma Ltd (SK GROUP) | +912266227575 | Maharashtra, India | 38 | 58 | Inquiry |
| Medi Pharma Drug House | +919930911911 | Mumbai, India | 143 | 58 | Inquiry |
| Mehta API Pvt. Ltd. | +91-9920552082 +91-9920552082 | Maharashtra, India | 33 | 58 | Inquiry |
| Humble Healthcare Limited | +91-9720093000 +91-8006400378 | Uttar Pradesh, India | 141 | 58 | Inquiry |
| Ralington Pharma | +91-7948911722 +91-9687771722 | Gujarat, India | 1350 | 58 | Inquiry |
| ShreeGen Pharma Ltd (part of Rumit Group of Companies) | +91-4023869399 +91-9664830616 | Telangana, India | 25 | 58 | Inquiry |
| Ishita Drugs And Industries Ltd | +91-7226995614 +91-7226995613 | Telangana, India | 47 | 58 | Inquiry |
| Century Pharmaceuticals Ltd | +91-2652361581 +91-2652361581 | Gujarat, India | 53 | 58 | Inquiry |
| Kalpdrum Enterprises | 91-22-24134436 | Maharashtra, India | 71 | 58 | Inquiry |
Related articles
- Chloramphenicol: Chemistry, Mechanism of Action and Pharmacokinetics
- Chloramphenicol inhibits bacterial protein synthesis via ribosomal binding, offering broad-spectrum bacteriostatic action with....
- Jul 11，2024
- The utility of chloramphenicol
- Chloramphenicol was the first of the clinically useful antibiotics to be synthesized and the only one which is marketed in syn....
- Jun 27，2022
- What is Chloramphenicol?
- Chloramphenicol was originally isolated from Streptomyces venezuelae. It competes with transfer RNA at the peptidyl transferas....
- Mar 21，2022
56-75-7(Chloramphenicol)Related Search:
1of4
chevron_right